GB8805268D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB8805268D0
GB8805268D0 GB888805268A GB8805268A GB8805268D0 GB 8805268 D0 GB8805268 D0 GB 8805268D0 GB 888805268 A GB888805268 A GB 888805268A GB 8805268 A GB8805268 A GB 8805268A GB 8805268 D0 GB8805268 D0 GB 8805268D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB888805268A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB888805268A priority Critical patent/GB8805268D0/en
Publication of GB8805268D0 publication Critical patent/GB8805268D0/en
Priority to DK104489A priority patent/DK104489A/en
Priority to BE8900222A priority patent/BE1002256A3/en
Priority to IL89472A priority patent/IL89472A0/en
Priority to IT8947714A priority patent/IT8947714A0/en
Priority to NL8900525A priority patent/NL8900525A/en
Priority to DE3906884A priority patent/DE3906884A1/en
Priority to GB8904879A priority patent/GB2216413A/en
Priority to KR1019890002612A priority patent/KR890014110A/en
Priority to JP1051813A priority patent/JP2834175B2/en
Priority to FR8902778A priority patent/FR2627985A1/en
Priority to ZA891640A priority patent/ZA891640B/en
Priority to AU30984/89A priority patent/AU3098489A/en
Priority to SE8900752A priority patent/SE8900752L/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
GB888805268A 1988-03-04 1988-03-04 Medicaments Pending GB8805268D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GB888805268A GB8805268D0 (en) 1988-03-04 1988-03-04 Medicaments
SE8900752A SE8900752L (en) 1988-03-04 1989-03-03 PHARMACEUTICAL COMPOSITION
DE3906884A DE3906884A1 (en) 1988-03-04 1989-03-03 Pharmaceutical product
KR1019890002612A KR890014110A (en) 1988-03-04 1989-03-03 Medication
IL89472A IL89472A0 (en) 1988-03-04 1989-03-03 Pharmaceutical compositions containing sufotidine for the treatment of inflammatory conditions
IT8947714A IT8947714A0 (en) 1988-03-04 1989-03-03 PHARMACEUTICAL COMPOSITION CONTAINING SUFOTIDINE AND METHOD FOR PREPARING AND APPLYING IT
NL8900525A NL8900525A (en) 1988-03-04 1989-03-03 MEDICINES CONTAINING SUFOTIDINE AND ITS USE.
DK104489A DK104489A (en) 1988-03-04 1989-03-03 APPLICATION OF TRIAZOLD DERIVATIVES
GB8904879A GB2216413A (en) 1988-03-04 1989-03-03 Medicaments containing sufotidine
BE8900222A BE1002256A3 (en) 1988-03-04 1989-03-03 DRUGS.
JP1051813A JP2834175B2 (en) 1988-03-04 1989-03-03 Medicine
FR8902778A FR2627985A1 (en) 1988-03-04 1989-03-03 COADMINISTRATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND SUFOTIDINE OR ONE OF ITS PHYSIOLOGICALLY ACCEPTABLE SALTS
ZA891640A ZA891640B (en) 1988-03-04 1989-03-03 Medicaments
AU30984/89A AU3098489A (en) 1988-03-04 1989-03-03 Sufotidine and systemic non-steroidal anti-inflammatory agents for the treatment of inflammations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888805268A GB8805268D0 (en) 1988-03-04 1988-03-04 Medicaments

Publications (1)

Publication Number Publication Date
GB8805268D0 true GB8805268D0 (en) 1988-04-07

Family

ID=10632893

Family Applications (2)

Application Number Title Priority Date Filing Date
GB888805268A Pending GB8805268D0 (en) 1988-03-04 1988-03-04 Medicaments
GB8904879A Withdrawn GB2216413A (en) 1988-03-04 1989-03-03 Medicaments containing sufotidine

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB8904879A Withdrawn GB2216413A (en) 1988-03-04 1989-03-03 Medicaments containing sufotidine

Country Status (12)

Country Link
JP (1) JP2834175B2 (en)
KR (1) KR890014110A (en)
AU (1) AU3098489A (en)
BE (1) BE1002256A3 (en)
DE (1) DE3906884A1 (en)
DK (1) DK104489A (en)
FR (1) FR2627985A1 (en)
GB (2) GB8805268D0 (en)
IT (1) IT8947714A0 (en)
NL (1) NL8900525A (en)
SE (1) SE8900752L (en)
ZA (1) ZA891640B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO300260B1 (en) 1993-05-05 1997-05-05 Torgersen Hans & Soenn Children's car seat
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
AU776609B2 (en) * 1999-09-24 2004-09-16 Novartis Ag Topical suspension formulations containing ciprofloxacin and dexamethasone
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
BRPI0918492A2 (en) 2008-09-09 2015-12-01 Astrazeneca Ab use of naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof
KR20120030106A (en) 2009-06-25 2012-03-27 아스트라제네카 아베 Method for treating a patient at risk for developing an nsaid-associated ulcer
WO2013101897A2 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655104A5 (en) * 1980-02-28 1986-03-27 Glaxo Group Ltd TRIAZOLIC HETEROCYCLIC DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME.
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
BE894286A (en) * 1981-09-04 1983-03-02 Glaxo Group Ltd PHARMACEUTICAL COMPOSITION CONTAINING NON-STEROID SYSTEMIC ANTI-INFLAMMATORY DRUG AND 1-METHYL-5 - ((3- (3- (3- (1-PIPERIDINYLMETHYL) PHENOXY) -PROPYL) AMINO -1H-1,2,4-TRIAZOLE-3- METHANOL OR A SALT OF THIS COMPOUND
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs

Also Published As

Publication number Publication date
ZA891640B (en) 1990-03-28
NL8900525A (en) 1989-10-02
SE8900752D0 (en) 1989-03-03
DE3906884A1 (en) 1989-09-14
KR890014110A (en) 1989-10-21
SE8900752L (en) 1989-09-05
FR2627985A1 (en) 1989-09-08
IT8947714A0 (en) 1989-03-03
DK104489A (en) 1989-09-05
DK104489D0 (en) 1989-03-03
BE1002256A3 (en) 1990-11-06
GB8904879D0 (en) 1989-04-12
JPH01316319A (en) 1989-12-21
GB2216413A (en) 1989-10-11
JP2834175B2 (en) 1998-12-09
AU3098489A (en) 1989-09-07

Similar Documents

Publication Publication Date Title
AP8900136A0 (en) Medicaments
GB8905400D0 (en) Medicaments
GB8816187D0 (en) Medicaments
ZA891639B (en) Medicaments
GB8904879D0 (en) Medicaments
GB8814726D0 (en) Medicaments
ZA896675B (en) Medicaments
GB8808599D0 (en) Medicaments
GB8820650D0 (en) Medicaments
ZA896674B (en) Medicaments
GB8814725D0 (en) Medicaments
GB8911166D0 (en) Medicaments
GB8828032D0 (en) Medicaments
GB8819479D0 (en) Medicaments
GB8814053D0 (en) Medicaments
GB8819707D0 (en) Medicaments
GB8819480D0 (en) Medicaments
GB8804110D0 (en) Medicaments
GB8816185D0 (en) Medicaments
GB8819708D0 (en) Medicaments
GB8822071D0 (en) Medicaments
GB8825392D0 (en) Medicaments
GB8814728D0 (en) Medicaments
GB8814727D0 (en) Medicaments
GB8814054D0 (en) Medicaments